Iron administration and clinical outcomes in hemodialysis patients.
Feldman HI, Santanna J, Guo WS, et al.
J Am Soc Nephrol 2002;13(3):734-744.
NATA Rating :
Review by : Gasche C
This study raises two important questions: First, are the observed adverse events upon high dose iron dextran users due to confounding variables such as comorbidity, or are they true iron dextran effects? Second, if they are true iron dextran effects, are they caused by the iron or the dextran?
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.